Brief: Ipsen Completes Acquisition Of Imcheck Therapeutics
15/12/2025 16:30
Dec 15 (Reuters) - Ipsen SA IPN.PA: IPSEN COMPLETES ACQUISITION OF IMCHECK THERAPEUTICS, EXPANDING ONCOLOGY PIPELINE Source text: nGNX1ynS1T Further company coverage: IPN.PA (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))
Recent news on Ipsen SA
See all newsFulcrum falls after discontinuing sickle cell drug program
Fulcrum falls after discontinuing sickle cell drug program
Fulcrum scraps sickle cell drug program after FDA raises cancer-risk concerns
Fulcrum Therapeutics falls after scrapping sickle cell drug development
Brief: Ipsen's IQIRVO Shows Meaningful Fatigue Improvements In Moderate-To-Severe PBC Patients